Indegene IPO: Lifesciences company to hit capital market to raise ~INR crores through public issue

Indegene is into Healthcare & Pharmaceuticals Lifesciences and is looking raise funds through Fresh Issue and Offer For Sale

Indegene IPO: Lifesciences company to hit capital market to raise ~INR  crores through public issue
Indegene to raise Fresh Issue aggregating up to Rs 950 crores and an Offer for Sale up to 36,291,497 Equity Shares through public issue IPO

Indegene IPO Update:

Indegene Limited IPO: Bengaluru based Indegene Limited established in the year 1998 and is into Healthcare & Pharmaceuticals - Lifesciences sector.


Company is promoted by The Company is a professionally managed company and does not have an identifiable promoter.. Pre-Offer Promoter and Promoter group stake in the company is .%.


Indegene Limited has filed Red Herring Prospectus (RHP) for proposed initial public offer (IPO). Total issue size is INR Crores calculated on upper price band (face value of INR 2 per share) via initial public offering.

Initial Public Offer comprising of a Fresh Issue of Equity shares aggregating up to Rs 950 Cr and an Offer for Sale of up to 36,291,497 Equity Shares Kotak Mahindra Capital, Citigroup Global, J.P.Morgan, Nomura Financial have been appointed as lead merchant bankers for the proposed IPO. It has appointed Link Intime (India) Pvt. Ltd. as Registrar and Share transfer Agent.

Details about upcoming IPO:
As per the details available in RHP, Price band is Rs 430 to Rs 452 with lot size of 33 shares and in multiples thereof. Objects of the issue is 1) Repayment / pre=payment of debt of one of the subsidiaries, 2) Funding the capex requirements of the company and subsidiaries., and 3) General corporate purpose and inorganic growth..

IPO Dates:

IPO will open on May 06, 2024 and close on May 06, 2024. Tentative date of listing on stock exchanges is May 13, 2024

Want to know more details about the IPO, please visit here Indegene Limited

Source: SEBI, BSE, NSE, DRHP, Indegene, Industry Data

Disclaimer: Above article only publishes details about the IPO and for educational purpose only. It doesn't solicit or invite any interest to invest in any kind of securities. Please visit respective sources to verify and know more details about the IPO. We advise investors to take opinion from certified/SEBI registered experts before taking any investment decisions.

Post a Comment

0 Comments